Preparation and pH stability of ferrous glycinate liposomes

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 7, 2009, Pages 2938-2944

  Ding, Baomiao ^a   Xia, Shuqin ^a   Hayat, Khizar ^a   Zhang, Xiaoming ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Encapsulation efficiency; Ferrous glycinate; Gastrointestinal juice; Liposomes; Stability

Indexed keywords

CHOLESTEROL; DRUG DERIVATIVE; FERROUS ION; GLYCINE; LIPOSOME; POLYSORBATE;

ARTICLE; CHEMISTRY; DIET SUPPLEMENTATION; DRUG FORMULATION; DRUG STABILITY; PARTICLE SIZE; PH; STOMACH JUICE; SYNTHESIS;

CHOLESTEROL; DIETARY SUPPLEMENTS; DRUG COMPOUNDING; DRUG STABILITY; FERROUS COMPOUNDS; GASTRIC JUICE; GLYCINE; HYDROGEN-ION CONCENTRATION; LIPOSOMES; PARTICLE SIZE; POLYSORBATES;

EID: 64549121131     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8031205     Document Type: Article

References (38)

1. Deegan, H.; Bates, H. M.; McCargar, L. J. Assessment of iron status in adolescents: dietary, biochemical and lifestyle determinants. J. Adolescent Health 2005, 37, 75.el575.e21.
2. Gaucheron, F. Iron fortification in dairy industry. Trends Food Sci. Technol. 2000, 11, 403-409.
3. Zimmermann, M. B.; Hurrell, R. F. Nutritional iron deficiency. Lancet. 2007, 370, 511-520.
4. Kloots, W.; Kamp, D. O.; Abrahamse, L. In vitro iron availability from iron-fortified whole-grain wheat flour. J. Agric. Food Chem. 2004, 52, 8132-8136.
5. Kapanidis, A. N.; Lee, T.-C. Novel method for the production of color-compatible ferrous sulfate-fortified simulated rice through extrustion. J. Agric. Food Chem. 1996, 44, 522-525.
6. Layrisse, M.; Garcia-Casal, M. N.; Solano, L.: Baron, M. A.; Arguello, F.; Llovera, D. Iron bioavailability in humans from breakfasts enriched with iron bis-glycine chelate, phylates and polyphenols. J. Nutr. 2000, 130, 2195-2199.
7. Olivares, M.; Pizarro, F.; Pineda, O.; Name, J. J.; Hertrampf, E.; Walter, T. Milk inhibits and ascorbic acid favors ferrous bis-glycine chelate bioavailability in humans. J. Nutr. 1997, 127, 1407-1411.
8. Jeppsen, R. B.; Borzelleca, J. F. Safety evaluation of ferrous bisglycinate chelate. Food Chem. Toxicol. 1999, 37, 723-731.
9. Bovell-Benjamin, A. C.; Viteri, F. E.; Allen, L. H. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am. J. Clin. Nutr. 2000, 71, 1563-1569.
10. Fox, T. E.; Eagles, J.; Fairweather-Tait, S. J. Bioavailability of iron glycine as a fortificant in infant foods. Am. J. Clin. Nutr. 1998, 67, 664-668.
11. Hallberg, L.; Hulthén, L. No advantage of using ferrous bisgly-cinate as an iron fortificant. Am. J. Clin. Nutr. 2000, 72, 1592-1593.
12. Kwak, H. S.; Yang, K. M.; Ahn, J. Microencapsulated iron for milk fortification. J. Agric. Food Chem. 2003, 51, 7770-7774.
13. Sharma, A.; Sharma, U. S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 1997, 154, 123-140.
14. Betz, G.; Aeppli, A.; Menshutina, N.; Leuenberger, H. In vivo comparison of various liposome formulations for cosmetic application. Int. J. Pharm. 2005, 296, 44-54.
15. Keller, B. C. Liposomes in nutrition. Trends Food Sci. Technol. 2001, 12, 25-31.
16. Were, L. M.; Bruce, B. D.; Davidson, P. M.; Weiss, J. Size, stability, and entrapment efficiency of phospholipids nanocapsules containing polypeptide antimicrobials. J. Agric. Food Chem. 2003, 51, 8073-8079.
17. Xia, S. Q.; Xu, S. Y. Ferrous sulfate liposomes: preparation, stability and application in fluid milk. Food Res. Int. 2005, 38, 289-296.
18. Gomez-Hens, A.; Fernadez-Romero, J. M. Analytical methods for the control of liposomal delivery systems. Trends Anal. Chem. 2006, 25, 167-178.
19. Lysionek, A. E.: Zubillaga, M. B.; Salgueiro, M. J.; Pineiro, A.; Caro, R. A.; Weill, R.; Boccio, J. R. Bioavailability of microencapsulated ferrous sulfate in powdered milk produced from fortified fluid milk: a prophylactic study in rats. Nutrition 2002, 18, 279-281.
20. Olivares, M. Bioavailability of microencapsulated ferrous sulfate in milk. Nutrition 2002, 18, 285-286.
21. Chen, H. M.; Torchilin, V.; Langer, R. Polymerized liposomes as potential oral vaccine carriers: stability and bioavailability. J. Controlled Release 1996, 42, 263-272.
22. Sun, W. T.; Zhang, N.; Li, A. G.; Zou, W. W.; Xu, W. F. Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int. J. Pharm. 2008, 353, 243-250.
23. Lasic D. D. Liposomes: from Physics to Application; Elsevier: Amsterdam, The Netherlands, 1993; pp 575.
24. Lee, K.; Clydesdale, F. M. Quantitative determination of the elemental, ferrous, ferric, soluble, and complexed iron in foods. J. Food Sci. 1979, 44, 549-554.
25. Agarwal, R.; Katare, O. P.; Vyas, S. P. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int. J. Pharm. 2001, 228, 43-52.
26. Laridi, R.; Kheadr, E. E.; Benech, R.-O.; Vuillemard, J. C.; Lacroix, C.; Fliss, I. Liposome encapsulated nisin Z: optimization, stability and release during milk fermentation. Int. Dairy J. 2003, 13, 325-336.
27. Fan, M. H.; Xu, S. Y.; Xia, S. Q.; Zhang, X. M. Effect of different preparation methods on physicochemical properties of salidroside liposomes. J. Agric. Food Chem. 2007, 55, 3089-3095.
28. Hara, T.; Liu, F.; Liu, D. X.; Huang, L. Emulsion formulations as a vector for gene delivery in vitro and in vivo. Adv. Drug Delivery Rev. 1997, 24, 265-271.
29. Yang, T.; Cui, F. D.; Choi, M. K.; Cho, J. W.; Chung, S. J.; Shim, C. K.; Kim, D. D. Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation. Int. J. Pharm. 2007, 338, 317-326.
30. Ceh, B.; Winterhalter, M.; Frederik, P. M.; Valler, J. J.; Lasic, D. D. Stealth® liposomes: from theory to product. Adv. Drug Delivery Rev. 1997, 24, 165-177.
31. Kronberg, B.; Dahlman, A.; Carlfors, J.; Karlsson, J.; Artursson, P. Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity. J. Pharm. Sci. 1990, 79, 667-671.
32. Gregoriadis, G. Liposome Technology: Vol. 1: Preparation of Liposomes; CRC Press: Boca Raton, FL, 1984; pp 15-16.
33. Gulati, M.; Grover, M.; Singh, S.; Singh, M. Lipophilic drug derivatives in liposomes. Int. J. Pharm. 1998, 165, 129-168.
34. Walde, P.; Sunamoto, J.; O'Connor, C. J. The mechanism of liposomal damage by taurocholate. Biochim. Biophys. Acta 1987, 905, 30-38.
35. Schubert, R.; Beyer, K.; Wolburg, H.; Schmidt, K. H. Structural changes in membranes of large unilamellar vesicles after binding of sodium cholate. Biochemistry 1986, 25, 5263-5269.
36. Schubert, R.; Schmidt, K. H. Structural changes in vesicle membranes and mixed micelles of various lipid compositions after binding of different bile salts. Biochemistry 1988, 27, 8787-8794.
37. Hollmann, A.; Delfederico, L.; Glikmann, G.; De Antoni, G.; Semorile, L.; Disalvo, E. A. Characterization of liposomes coated with S-layer proteins from lactobacilli. Biochim. Biophys. Acta 2007, 1768, 393-400.
38. Acosta, E. Bioavailability of nanoparticles in nutrient and nutra-ceutical delivery. Curr. Opin. Colloid Interface Sci. 2009, 14, 3-15.